Paul Kirschmeier Selected Research

Paul Kirschmeier Research Topics

Disease

23	Neoplasms (Cancer) 01/2019 - 04/2002
5	Breast Neoplasms (Breast Cancer) 01/2019 - 04/2005
3	Lung Neoplasms (Lung Cancer) 01/2021 - 03/2014
3	Ovarian Neoplasms (Ovarian Cancer) 04/2008 - 06/2003
2	Melanoma (Melanoma, Malignant) 01/2018 - 07/2013
2	Retinoblastoma (Glioblastoma, Retinal) 10/2017 - 08/2010
2	Fever (Fevers) 10/2017 - 05/2004
2	Carcinogenesis 09/2008 - 02/2002
2	Diarrhea 07/2007 - 05/2004
1	Adenocarcinoma of Lung 01/2019
1	Nausea 01/2019
1	Ovarian Epithelial Carcinoma 01/2019
1	Hyperuricemia 10/2017
1	Pancytopenia 10/2017
1	Hypotension (Low Blood Pressure) 10/2017
1	Orthostatic Hypotension (Postural Hypotension) 10/2013
1	Prostatic Neoplasms (Prostate Cancer) 12/2009
1	Hematologic Neoplasms (Hematological Malignancy) 12/2009
1	Brain Neoplasms (Brain Tumor) 07/2007
1	Central Nervous System Neoplasms 07/2007
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2004
1	Neutropenia 05/2004
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2004
1	Leukemia 01/2003

Drug/Important Bio-Agent (IBA)

8	lonafarnib (SCH 66336)IBA 12/2009 - 08/2002
5	Farnesyltranstransferase (Farnesyltransferase)IBA 12/2009 - 05/2004
5	TransferasesIBA 04/2008 - 02/2002
3	Cell-Free Nucleic AcidsIBA 01/2018 - 03/2014
3	dinaciclibIBA 10/2017 - 08/2010
3	Taxoids (Taxanes)IBA 10/2011 - 01/2006
3	Proteins (Proteins, Gene)FDA Link 04/2008 - 02/2002
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 07/2013
2	MK-8353IBA 07/2018 - 01/2018
2	SCH772984IBA 01/2018 - 07/2013
2	Aromatase InhibitorsIBA 01/2018 - 09/2007
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2017 - 10/2013
2	Docetaxel (Taxotere)FDA Link 12/2009 - 09/2005
2	Hormones (Hormone)IBA 12/2009 - 09/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2008 - 05/2004
2	Tamoxifen FDA LinkGeneric 09/2007 - 09/2005
2	Small Interfering RNA (siRNA)IBA 05/2007 - 04/2005
2	taxaneIBA 09/2005 - 05/2004
2	Complementary DNA (cDNA)IBA 04/2005 - 06/2003
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2019
1	AlpelisibIBA 01/2019
1	olaparibIBA 01/2019
1	ArginaseIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	3(S)-thiomethyl pyrrolidineIBA 07/2018
1	Transaminases (Aminotransferases)IBA 10/2017
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2014
1	Uric Acid (Urate)IBA 10/2013
1	Mitogen-Activated Protein KinasesIBA 07/2013
1	SCH 1473759IBA 10/2011
1	Bromodeoxyuridine (BrdU)IBA 08/2010
1	Monomeric GTP-Binding ProteinsIBA 09/2008
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 09/2008
1	p21(ras) farnesyl-protein transferase (protein farnesyltransferase)IBA 04/2008
1	Anastrozole (Arimidex)FDA LinkGeneric 09/2007
1	Estrogen Receptor Modulators (Antiestrogen)IBA 09/2007
1	Aromatase (CYP19)IBA 09/2007
1	Loperamide (Imodium)FDA LinkGeneric 07/2007
1	Protein Isoforms (Isoforms)IBA 05/2007
1	Phosphotransferases (Kinase)IBA 05/2007
1	Biomarkers (Surrogate Marker)IBA 05/2007
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2007
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2006
1	Messenger RNA (mRNA)IBA 04/2006
1	LigandsIBA 04/2006
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2006
1	Inhibitor of Apoptosis ProteinsIBA 04/2002
1	SurvivinIBA 04/2002

Therapy/Procedure

2	Therapeutics 07/2018 - 02/2014
1	Aftercare (After-Treatment) 04/2008